Photobiomodulation Dosimetry s in Patients With Orofacial Pain
NCT ID: NCT06065969
Last Updated: 2023-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2023-10-10
2024-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction
NCT06068959
Photobiomodulation With Red and Infrared LED Device for Temporomandibular Dysfunction
NCT03696706
Photobiomodulation In the Masseter and Temporal In Patients With Temporomandibular Joint Dysfunction
NCT03005730
Effects of Photobiomodulation With Superpulsed Laser and Dual Wavelengths in Children and Adolescents
NCT07031505
Effect of Phototherapy in Individuals With Temporomandibular Disorder.
NCT02018770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local photobiomodulation
Delivering an energy of 6J per point (60 seconds) at 2 points in the masseter muscle region, 1 point in the temporal muscle, and 1 point in the trapezius muscle in the cervical region. The total application will take 4 minutes per session
Photobiomodulation
660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session.
Vascular photobiomodulation
660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session. The participant will be seated in a comfortable chair with side support for resting their arms during the application
Photobiomodulation
660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session.
sham local photobiomodulation
The same procedures described for local photobiomodulation will be followed; however, the equipment will emit only the sound signal, exactly like the equipment used in local photobiomodulation group, without emitting laser light.
Photobiomodulation
660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session.
Sham Vascular photobiomodulation
The same procedures described for vascular photobiomodulation will be followed; however, the equipment will emit only the sound signal, exactly like the equipment used in vascular photobiomodulation group, without emitting laser light
Photobiomodulation
660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Photobiomodulation
660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Pregnant individuals Individuals with arrhythmia Individuals with Thrombocytopenia Individuals with Sickle Cell Anemia Individuals with a pacemaker Individuals with alterations in coagulation factors
7 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nove de Julho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lara Jansiski Motta
Principal Researcher
References
Explore related publications, articles, or registry entries linked to this study.
Schuler SSV, Campos MCV, Lacerda AJ, Mazzoni AC, Silva T, Silva FCD, Martins MD, Fernandes KPS, Fonseca ES, Mesquita-Ferrari RA, Horliana ACRT, Bussadori SK, Motta LJ. Dosimetry model for photobiomodulation based on anthropometric and hemodynamic variables in patients with orofacial pain post-Covid-19: Study protocol for randomized clinical trial. PLoS One. 2024 Oct 15;19(10):e0309073. doi: 10.1371/journal.pone.0309073. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.